Cross-immunity between strains explains the dynamical pattern of paramyxoviruses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 43, 2015, Pages 13396-13400

  Bhattacharyya, Samit ^a,b   Gesteland, Per H ^c   Korgenski, Kent ^c,d   Bjørnstad, Ottar N ^a,e   Adler, Frederick R ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d INTERMOUNTAIN HEALTHCARE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cross immunity; Human parainfluenza; Paramyxoviruses; Pathogen interactions; Respiratory syncytial Viruses

Indexed keywords

ARTICLE; CONVALESCENCE; CROSS PROTECTION; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; HUMAN PARAINFLUENZA VIRUS 1; HUMAN PARAINFLUENZA VIRUS 2; HUMAN PARAINFLUENZA VIRUS 3; HUMAN RESPIRATORY SYNCYTIAL VIRUS; MOLECULAR PHYLOGENY; NONHUMAN; PARAINFLUENZA VIRUS INFECTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SEASONAL VARIATION; UNITED STATES; VIRUS STRAIN; VIRUS TRANSMISSION; BIOLOGICAL MODEL; EPIDEMIC; IMMUNOLOGY; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; PREVALENCE; RESPIROVIRUS; SEASON; SPECIES DIFFERENCE;

CROSS PROTECTION; DISEASE OUTBREAKS; HUMANS; METAPNEUMOVIRUS; MODELS, IMMUNOLOGICAL; PARAMYXOVIRIDAE INFECTIONS; PREVALENCE; RESPIRATORY SYNCYTIAL VIRUSES; RESPIROVIRUS; SEASONS; SPECIES SPECIFICITY;

EID: 84945547301     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1516698112     Document Type: Article

References (57)

1. Kitchen A, Shackelton LA, Holmes EC (2011) Family level phylogenies reveal modes of macroevolution in RNA viruses. Proc Natl Acad Sci USA 108(1):238-243.
2. Tregoning JS, Schwarze J (2010) Respiratory viral infections in infants: Causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 23(1):74-98.
3. Hall CB (2001) Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344(25):1917-1928.
4. Nascimento JP, et al. (1991) Longitudinal study of acute respiratory diseases in Rio de Janeiro: Occurrence of respiratory viruses during four consecutive years. Rev Inst Med Trop Sao Paulo 33(4):287-296.
5. Weber MW, et al. (2002) An epidemiological study of RSV infection in the Gambia. Bull World Health Organ 80(7):562-568.
6. van der Sande MA, Goetghebuer T, Sanneh M, Whittle HC, Weber MW (2004) Seasonal variation in respiratory syncytial virus epidemics in the Gambia, West Africa. Pediatr Infect Dis J 23(1):73-74.
7. Iwane MK, et al.; New Vaccine Surveillance Network (2004) Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113(6):1758-1764.
8. Weinberg GA, et al.; New Vaccine Surveillance Network (2009) Parainfluenza virus infection of young children: Estimates of the population-based burden of hospitalization. J Pediatr 154(5):694-699.
9. Fry AM, et al. (2006) Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis 43(8):1016-1022.
10. Reed G, Jewett PH, Thompson J, Tollefson S, Wright PF (1997) Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J Infect Dis 175(4):807-813.
11. Stensballe LG, Devasundaram JK, Simoes EA (2003) Respiratory syncytial virus epidemics: The ups and downs of a seasonal virus. Pediatr Infect Dis J 22(2 Suppl): S21-S32.
12. Jalal H, et al. (2007) Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. J Clin Microbiol 45(6):1690-1696.
13. Leader S, Kohlhase K (2003) Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 143(5 Suppl):S127-S132.
14. Paramore LC, Ciuryla V, Ciesla G, Liu L (2004) Economic impact of respiratory syncytial virus-related illness in the US: An analysis of national databases. Pharmacoeconomics 22(5):275-284.
15. Mullins JA, et al. (2004) Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis 10(4):700-705.
16. Dowell SF, et al. (1996) Respiratory syncytial virus is an important cause of communityacquired lower respiratory infection among hospitalized adults. J Infect Dis 174(3): 456-462.
17. Marx A, et al. (1999) Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection. Clin Infect Dis 29(1):134-140.
18. Schmidt AC, et al. (2011) P. L. Progress in the Development of Human Parainfluenza Virus Vaccines (Informa Healthcare, London).
19. Glezen WP, Taber LH, Frank AL, Kasel JA (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140(6):543-546.
20. Hall CB, Walsh EE, Long CE, Schnabel KC (1991) Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163(4):693-698.
21. Altizer S, et al. (2006) Seasonality and the dynamics of infectious diseases. Ecol Lett 9(4):467-484.
22. Fisman DN (2007) Seasonality of infectious diseases. Annu Rev Public Health 28: 127-143.
23. Dushoff J, Plotkin JB, Levin SA, Earn DJD (2004) Dynamical resonance can account for seasonality of influenza epidemics. Proc Natl Acad Sci USA 101(48):16915-16916.
24. Schwartz J (1996) Air pollution and hospital admissions for respiratory disease. Epidemiology 7(1):20-28.
25. Schwartz J (1995) Short term fluctuations in air pollution and hospital admissions of the elderly for respiratory disease. Thorax 50(5):531-538.
26. Casagrandi R, Bolzoni L, Levin SA, Andreasen V (2006) The SIRC model and influenza A. Math Biosci 200(2):152-169.
27. Adler FR, Clay CA, Lehmer EM (2008) The role of heterogeneity in the persistence and prevalence of Sin Nombre virus in deer mice. Am Nat 172(6):855-867.
28. Collins PL, Graham BS (2008) Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 82(5):2040-2055.
29. Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ (1998) Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol 79(Pt 9):2221-2229.
30. Pascalis H, et al. (2012) Intense co-circulation of non-influenza respiratory viruses during the first wave of pandemic influenza pH1N1/2009: A cohort study in Reunion Island. PLoS One 7(9):e44755.
31. Fé MM, Monteiro AJ, Moura FE (2008) Parainfluenza virus infections in a tropical city: Clinical and epidemiological aspects. Braz J Infect Dis 12(3):192-197.
32. Lindquist SW, Darnule A, Istas A, Demmler GJ (1997) Parainfluenza virus type 4 infections in pediatric patients. Pediatr Infect Dis J 16(1):34-38.
33. Leecaster M, et al. (2011) Modeling the variations in pediatric respiratory syncytial virus seasonal epidemics. BMC Infect Dis 11:105.
34. Bang FB (1975) Epidemiological interference. Int J Epidemiol 4(4):337-342.
35. White LJ, Waris M, Cane PA, Nokes DJ, Medley GF (2005) The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: Seasonality and cross-protection. Epidemiol Infect 133(2):279-289.
36. Tang RS, et al. (2004) Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys. J Virol 78(20):11198-11207.
37. Adams B, et al. (2006) Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci USA 103(38):14234-14239.
38. Kamo M, Sasaki A (2002) The effect of cross-immunity and seasonal forcing in a multistrain epidemic model. Physica D: Nonlinear Phenomena 165(3):228-241.
39. Lavenu A, Valleron AJ, Carrat F (2004) Exploring cross-protection between influenza strains by an epidemiological model. Virus Res 103(1-2):101-105.
40. Nuno M, Feng Z, Martcheva M, Castillo-Chavez C (2005) Dynamics of two-strain influenza with isolation and partial cross-immunity. SIAM Journal on Applied Mathematics 65(3):964-982.
41. Koelle K, Pascual M, Yunus M (2006) Serotype cycles in cholera dynamics. Proc Biol Sci 273(1603):2879-2886.
42. Recker M, et al. (2009) Immunological serotype interactions and their effect on the epidemiological pattern of dengue. Proc Biol Sci 276(1667):2541-2548.
43. Rohani P, Green CJ, Mantilla-Beniers NB, Grenfell BT (2003) Ecological interference between fatal diseases. Nature 422(6934):885-888.
44. Huang Y, Rohani P (2006) Age-structured effects and disease interference in childhood infections. Proc Biol Sci 273(1591):1229-1237.
45. Anderson RM, May RM (1992) Infectious Diseases of Humans: Dynamics and Control (Oxford Univ Press, London).
46. Vasco DA, Wearing HJ, Rohani P (2007) Tracking the dynamics of pathogen interactions: Modeling ecological and immune-mediated processes in a two-pathogen single-host system. J Theor Biol 245(1):9-25.
47. Rohani P, Keeling MJ, Grenfell BT (2002) The interplay between determinism and stochasticity in childhood diseases. Am Nat 159(5):469-481.
48. Wearing HJ, Rohani P (2006) Ecological and immunological determinants of dengue epidemics. Proc Natl Acad Sci USA 103(31):11802-11807.
49. Ferguson N, Anderson R, Gupta S (1999) The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc Natl Acad Sci USA 96(2):790-794.
50. Nelson NP, Brownstein JS, Hartley DM (2010) Event-based biosurveillance of respiratory disease in Mexico, 2007-2009: Connection to the 2009 influenza A(H1N1) pandemic? Euro Surveill 15(30):19626.
51. King AA, Domenech de Cellès M, Magpantay FM, Rohani P (2015) Avoidable errors in the modelling of outbreaks of emerging pathogens, with special reference to Ebola. Proc Biol Sci 282(1806):20150347.
52. van Boheemen S, et al. (2012) A family-wide RT-PCR assay for detection of paramyxoviruses and application to a large-scale surveillance study. PLoS One 7(4):e34961.
53. Rohani P, Earn DJ, Finkenstädt B, Grenfell BT (1998) Population dynamic interference among childhood diseases. Proc Biol Sci 265(1410):2033-2041.
54. Murphy BR, Collins PL (2002) Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: Applications of reverse genetics. J Clin Invest 110(1):21-27.
55. Rudraraju R, Jones BG, Sealy R, Surman SL, Hurwitz JL (2013) Respiratory syncytial virus: Current progress in vaccine development. Viruses 5(2):577-594.
56. State-wise Population Estimates: United States Census Bureau. Available at www.census.gov/popest/data/state/totals/2014/index.html. Accessed October 3, 2015.
57. Burnham KP, Anderson DR (2002) Model Selection and Multimodel Inference-A Practical Information-Theoretic Approach (Springer, New York).